Dr. Todd Cooper, Oncology section chief and director of Seattle Children’s Pediatric Leukemia/Lymphoma Program, as well as principal investigator in the Ben Towne Center for Childhood Cancer Research, has been appointed to chair the Children’s Oncology Group (COG) Myeloid Committee, effective May 1.
The COG is the largest consortium of pediatric hospitals providing oncology services in the world. It unites more than 10,000 cancer experts at about 250 hospitals across North America, Australia and New Zealand.
Cooper, who is also a professor of pediatrics at the University of Washington School of Medicine and the Evans Family Endowed Chair in Pediatric Cancer, will be responsible for setting COG’s vision and priorities for clinical/translational research and clinical care for pediatric and young adult malignancies, including acute myeloid leukemia (AML), acute myeloid leukemia of Down syndrome (AML-DS), chronic myelogenous leukemia (CML) and other myeloproliferative neoplasms.
He will work with experts throughout COG institutions to develop and conduct blood cancer clinical trials and protocols, as well as working with other international AML consortia to ensure COG’s clinical/translational priorities are synchronized and complementary. Read full post »
An innovative new outpatient space for the Cancer and Blood Disorders Center (CBDC) and Pediatric Blood and Marrow Transplant (BMT) Program officially opened this week on two floors of Seattle Children’s newest building called Forest B. It nearly doubles CBDC’s clinical outpatient capacity to help Seattle Children’s meet the growing need for pediatric services in the region.The physical and operational design of the new space reflects Seattle Children’s commitment to a patient care model that brings complex care teams together in a single location, with the patient at the center.
“Our model of care sets us apart from any other program in the country,” said Dr. Mignon Loh, division chief of Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy at Seattle Children’s and director of the Ben Towne Center for Childhood Cancer Research at Seattle Children’s Research Institute. “It’s a new paradigm, and it shows how Seattle Children’s is at the forefront of improving the patient experience.”
Read full post »
Seattle Children’s is working in partnership with Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Cancer Care Alliance (SCCA) to explore restructuring our longtime relationship to accelerate our shared mission of advancing diagnosis, treatment and pioneering of cures for cancer and other diseases. If the proposed restructure is finalized and approved, it will establish an adult-focused oncology program and a separate pediatric oncology program that operate collaboratively and will integrate the innovative cancer research from Fred Hutch, UW Medicine and Seattle Children’s.
Read full post »
Dr. Mignon Loh – New Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy Division Chief and BTCCCR Center Director
Message from Dr. Leslie Walker-Harding, chair, University of Washington School of Medicine Department of Pediatrics; senior vice president and chief academic officer, Seattle Children’s
I am thrilled to announce that on Dec. 1 Dr. Mignon Loh will join the University of Washington (UW) School of Medicine’s Department of Pediatrics as division chief of Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy. In this role, she will provide clinical leadership at Seattle Children’s Cancer and Blood Disorders Center and research leadership as center director of the Ben Towne Center for Childhood Cancer Research (BTCCCR) at Seattle Children’s Research Institute. Loh will also serve as professor in the Department of Pediatrics at the UW School of Medicine, as well as head of the Section of Pediatric Oncology at Fred Hutchinson Cancer Research Center (Fred Hutch). Read full post »
Work-Up and Management of Pediatric Urologic Conditions
Wednesday, Oct. 28, 5:30 to 6:45 p.m. MDT (Webex)
New Thoughts and Algorithms for Workup and Management of Pediatric Urologic Conditions
Category II CME credit
Speakers: Drs. Paul Merguerian, MD, MS, and Mark Cain, and Carlyn Doyle, NP
RSVP by Oct. 27 to Kenton.mcallister@seattlechildrens.org or mswanson@communitymed.org. Read full post »
For many patients undergoing treatment for cancer, there is not just the immediate worry about beating the disease but also the longer-term prospect of surviving the harsh side effects of the drugs that saved them. Almost five years ago, On the Pulse featured a clinical trial led by Dr. Todd Cooper to study the safety and efficacy of a cancer drug called CPX-351. Cooper and his team wanted to find out if CPX-351 could help young cancer patients survive their disease without the long-term cardiac damage so often caused by other drugs. Read full post »
In honor of Childhood Cancer Awareness Month, we would like to share with you the following information on T-Cell Immunotherapy at Seattle Children’s. For more information visit www.seattlechildrens.org/t-cell-trials. 
Seattle Children’s doctors and researchers are leading efforts to better treat cancer in children, adolescents and young adults by boosting the immune system with T-cell immunotherapy. Patients who cannot be cured with standard therapies are benefiting from clinical trials developed at the Ben Towne Center for Childhood Cancer Research, and supported by the Strong Against Cancer initiative.
One of these patients is Aaron. When he feared he might be out of treatment options, Aaron found hope at Seattle Children’s.
Read Aaron’s story on Seattle Children’s blog On The Pulse.
Read full post »
